0

539470

SHREEGANES

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Shree Ganesh Biotech (India) L Share Price Today

Investment Returns

Over 1 Month -3.33% Over 3 Months 0.00% Over 6 Months -6.45% Over 1 Year -34.83%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Shree Ganesh Biotech (India) L fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 23.50
  • P/E Ratio (TTM) 60.00
  • Beta 0.48
  • Book Value / share 1.59
  • Return on equity 0.44%
  • EPS (TTM) 0.01
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.15
info icon alternate text

Shree Ganesh Biotech (India) L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 2.12
Operating Expense 2.55
Net Profit -0.15
Net Profit Margin (%) -7.07
Earnings Per Share (EPS) 0.00
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 0.70
Operating Expense 0.75
Net Profit 0.32
Net Profit Margin (%) 45.71
Earnings Per Share (EPS) 0.01
EBITDA 0.32
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.77
Operating Expense 1.16
Net Profit 0.01
Net Profit Margin (%) 1.29
Earnings Per Share (EPS) 0.00
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.38
Operating Expense 1.47
Net Profit 0.33
Net Profit Margin (%) 23.91
Earnings Per Share (EPS) 0.01
EBITDA 0.33
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 3.01
Operating Expense 4.42
Net Profit -0.95
Net Profit Margin (%) -31.56
Earnings Per Share (EPS) -0.02
EBITDA -0.95
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 4.97
Operating Expense 5.93
Net Profit 0.38
Net Profit Margin (%) 7.64
Earnings Per Share (EPS) 0.01
EBITDA 0.51
Effective Tax Rate (%) 27.45
Particulars MAR 2025 (Values in Cr)
Revenue 22.96
Operating Expense 24.01
Net Profit 0.28
Net Profit Margin (%) 1.21
Earnings Per Share (EPS) 0.01
EBITDA 0.39
Effective Tax Rate (%) 28.20
Particulars MAR 2024 (Values in Cr)
Revenue 20.28
Operating Expense 20.48
Net Profit 0.62
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.02
EBITDA 0.85
Effective Tax Rate (%) 27.05
Particulars MAR 2023 (Values in Cr)
Revenue 62.45
Operating Expense 60.31
Net Profit 2.04
Net Profit Margin (%) 3.26
Earnings Per Share (EPS) 0.05
EBITDA 2.71
Effective Tax Rate (%) 25.09
Particulars MAR 2022 (Values in Cr)
Revenue 72.64
Operating Expense 69.20
Net Profit 2.53
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 0.13
EBITDA 3.50
Effective Tax Rate (%) 27.71
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1.59
ROE % 0.44
ROCE % 0.62
Total Debt to Total Equity 0.00
EBITDA Margin 1.70
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.58
ROE % 0.99
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 4.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.56
ROE % 3.33
ROCE % 4.43
Total Debt to Total Equity 0.00
EBITDA Margin 4.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.03
ROE % 4.28
ROCE % 5.92
Total Debt to Total Equity 0.00
EBITDA Margin 4.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.00
ROE % 0.92
ROCE % 1.23
Total Debt to Total Equity 0.00
EBITDA Margin 4.13
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 63.48
Total Liabilities 63.48
Total Equity 63.25
Share Outstanding 39
Price to Book Ratio 0.57
Return on Assets (%) 0.43
Return on Capital (%) 0.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 73.62
Total Liabilities 73.62
Total Equity 62.97
Share Outstanding 39
Price to Book Ratio 0.66
Return on Assets (%) 0.84
Return on Capital (%) 0.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 79.52
Total Liabilities 79.52
Total Equity 62.35
Share Outstanding 39
Price to Book Ratio 0.65
Return on Assets (%) 2.56
Return on Capital (%) 3.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 93.55
Total Liabilities 93.55
Total Equity 60.31
Share Outstanding 19
Price to Book Ratio 3.07
Return on Assets (%) 2.69
Return on Capital (%) 4.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 74.62
Total Liabilities 74.62
Total Equity 57.79
Share Outstanding 1
Price to Book Ratio 4.09
Return on Assets (%) 0.42
Return on Capital (%) 0.55
Particulars MAR 2025 (Values in Cr)
Net Income 0.38
Cash from Operations -10.21
Cash from Investing 9.79
Cash from Financing 0.00
Net change in Cash -0.41
Free Cash Flow -10.21
Particulars MAR 2024 (Values in Cr)
Net Income 0.85
Cash from Operations 10.15
Cash from Investing -10.20
Cash from Financing 0.00
Net change in Cash -0.05
Free Cash Flow 10.15
Particulars MAR 2023 (Values in Cr)
Net Income 2.71
Cash from Operations 11.21
Cash from Investing -10.09
Cash from Financing 0.00
Net change in Cash 0.44
Free Cash Flow 11.21
Particulars MAR 2022 (Values in Cr)
Net Income 3.49
Cash from Operations 4.54
Cash from Investing -3.36
Cash from Financing -0.19
Net change in Cash 0.01
Free Cash Flow 4.54
Particulars MAR 2021 (Values in Cr)
Net Income 0.42
Cash from Operations 2.47
Cash from Investing -2.35
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 2.47
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD. 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD. 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.80 14.94 2.45 997.12 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2120.70 37.34 15.84 35925.94 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTAJAN HEALTH LTD 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA IND LT 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 438.10 47.26 4.02 4646.32 118.35 462.70

Shree Ganesh Biotech (India) L shareholding pattern

Holding
98.57%
1.42%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)

Shree Ganesh Biotech (India) L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
0.59 -1.66 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 0.60
  • 26 Days 0.60
  • 10 Days 0.60
  • 50 Days 0.60
  • 12 Days 0.60
  • 100 Days 0.60
  • 20 Days 0.60
  • 200 Days 0.70
0.56 PIVOT
First Support 0.53 First Resistance 0.61 Second Support 0.48 Second Resistance 0.64 Third Support 0.45 Third Resistance 0.69
RSI 41.76 ADX 38.39 MACD -0.01 Williams % R -45.45 Commodity Channel Index (CCI) -197.94
Date 2026-06-12 Week 331171.00 Same Day 546878.00 Month 363438.00
1 Year 0.47 3 Year 0.49
Over 1 Month
-3.33% down
Over 1 Year
-34.83% down
Over 3 Months
0.00% down
Over 3 Years
-18.71% down
Over 6 Months
-6.45% down
Over 5 Years
-36.96% down

Shree Ganesh Biotech (India) L Corporate Actions

Ex-Date Ex-Bonus Ratio
28 Apr 2022 27 Apr 2022 1:1
Ex-Date Old FV NEW FV Record Date
10 Feb 2022 10.0 1.0 11 Feb 2022

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shree Ganesh Biotech India Ltd?

Answer Field

Shree Ganesh Biotech India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.59 as on Jun 16 2026 03:30 PM.

What is the Market Cap of Shree Ganesh Biotech India Ltd Share?

Answer Field

The market cap of Shree Ganesh Biotech India Ltd for NSE ₹ 0.00 & for BSE ₹ 23.50 as on Jun 16 2026 03:30 PM.

What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?

Answer Field

The 52 Week High and Low of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 0.89 and ₹ 0.52.

What is 1 year return for Shree Ganesh Biotech India Ltd?

Answer Field

The 1 year returns on the stock has been -31.81%.

What is the P/E Ratio of Shree Ganesh Biotech India Ltd Share?

Answer Field

As on Jun 16 2026 03:30 PM the price-to-earnings (PE) ratio for Shree Ganesh Biotech India Ltd share is 60.00.

What is the PB ratio of Shree Ganesh Biotech India Ltd Share?

Answer Field

As on Jun 16 2026 03:30 PM, the price-to-book (PB) ratio for Shree Ganesh Biotech India Ltd share is 1.59.

How to Buy Shree Ganesh Biotech India Ltd Share?

Answer Field

You can trade in Shree Ganesh Biotech India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Ganesh Biotech India Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Ganesh Biotech India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Ganesh Biotech India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|